Drexel study reports that Rapamycin may slow skin aging.
Rapamycin, an FDA-approved drug normally used to prevent organ rejection after transplant surgery, may also slow aging in human skin, according to a study from Drexel University College of Medicine researchers published in Geroscience. Rapamycin is an FDA-approved drug that’s normally used to stop organ rejection following transplant surgery. According to Drexel University College of Medicine research published in Geroscience, it may also be able to slow down aging of the skin.
The drug has been used in basic science studies to slow down aging in mice and worms. However, the current study shows that it also reduces signs of aging on human skin. When applied topically, the drug can reduce wrinkles and sagging as well as improve skin tone.
As researchers continue to search for the elusive \”fountain of youthfulness\” and ways to prolong life, we see a growing potential to use this drug, said Christian Sell, PhD., an associate Professor of Biochemistry, Molecular Biology, and the College of Medicine. \”We decided to try the skin. The skin is a complex organ with nerve, immune and stem cells. You can learn about the biology of the drug by looking at the skin.\”